Clinical Trial Update: The CIRCADIAN Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether galantamine can modulate circadian rhythm in patients with mild to moderate Alzheimer's disease; the study was terminated and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Galantamine (galantamine)

Snippet

Sponsor: Janssen-Cilag, S.A. | Conditions: Alzheimer Disease | Phase 4 | Status: TERMINATED | Results posted: 2012-08-14